Showing results (141-150 of 164) with videos related to
Sort By:
Pageof 17
Therapeutic Advances in Medical Oncology|June 30, 2025
Frequency of driver oncogenic alterations in NSCLC and estimated indoor radon exposure in Europe (RADON EUROPE study)Miguel García-Pardo, Marta García de Herreros, Edouard Auclin, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2016
The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLCChristian Manegold, Anne-Marie C Dingemans, Jhanelle E Gray, et al.Cancer Immunology, Immunotherapy : CII|August 2, 2024
Negative association of steroids with immunotherapy efficacy in a multi-tumor cohort: time and dose-dependentVíctor Albarrán, Patricia Guerrero, Coral García de Quevedo, et al.JCO Precision Oncology|November 14, 2025
Actionable Genomic Alterations in Large Cell Neuroendocrine Carcinoma: A European Case Series of Patients Treated With a Small Molecule InhibitorFrank W J Heijboer, Marta Brambilla, Mario Occhipinti, et al.Thrombosis Research|November 17, 2023
Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancerInmaculada Aparicio, Patricia Iranzo, Roxana Reyes, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2019
Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO expertsPaul M Putora, Markus Glatzer, José Belderbos, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2019
Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO expertsPaul Martin Putora, Markus Glatzer, Dirk De Ruysscher, et al.The Oncologist|October 19, 2024
Detrimental effect of an early exposure to antibiotics on the outcomes of immunotherapy in a multi-tumor cohort of patientsPatricia Guerrero, Víctor Albarrán, Carlos González-Merino, et al.BMC Cancer|March 7, 2021
Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer GroupMariano Provencio, Josefa Terrasa, Pilar Garrido, et al.JTO Clinical and Research Reports|March 25, 2024
RET Fusion Testing in Patients With NSCLC: The RETING StudyEsther Conde, Susana Hernandez, Jose Luis Rodriguez Carrillo, et al.Pageof 17